THE BARCELONA CLINIC LIVER CANCER
PRESENTS A SPECIAL COURSE ON
PROGRAM FOR THE ADVANCEMENT OF
THERAPY IN HEPATOCELLULAR CARCINOMA (PATH)
3–4 MART 2014
BARCELONA, SPAIN
Hepatosellüler karsinoma (PATH) içinde Tedavisi İlerlemesi İçin Program Barselona, İspanya Barcelona
Hastanesi Kliniğinde Karaciğer Kanseri için Barselona Kliniği (BCLC) de yapılacaktır.
PATH Programın amacı, HCC tedavisinde uzman ve araştırma ya da HCC yönetimini geliştirmek atılım klinik
uygulamaları ile HCC yönetimi ilerleyen onların liderlik için tanınan mükemmeliyet merkezleri arasındaki iyi
uygulamaların alışverişini kolaylaştıran bir forum oluşturmaktır.
AGENDA
Monday 3 March 2014
J. Bruix, Chair
09:00-09:10
Welcome and Introduction
J. Bruix
09:10-09:45
Current Risk Factors for HCC and Changing Epidemiology Profile
M. Beaugrand
09:45-10:15
Expected Impact of Novel Antivirals in HCC Epidemiology and
Management
M. Colombo
10:15-10:30
Questions & Answer for Dr. Beaugrand and Dr. Colombo
10:30 – 11:00
Molecular Mechanisms in Preclinical Models and Genomic
Profiling
J. M. Llovet
11:00 – 11:15
Question & Answer
11:15 - 11:45
Coffee Break
11:45 - 12:15
Screening Strategies and Their Cost-Effectiveness
A.Forner
12:15 – 12:45
Diagnosis, Staging and Evaluation of response to treatment by
Radiology
C.Ayuso
12:45 - 13:00
Question & Answer
13:00 - 14:00
Lunch and Group Photo
14:00-14:30
Case Studies: Diagnosis and Staging of HCC
J. Bruix, A. Liccioni, M. Solé, and C. Ayuso
14:30-15:15
Systemic Therapies in the Management of Advanced HCC:
Current Status and Future Perspectives
M. Reig
15:15 – 15:45
Controversial Scenarios in Staging and Treatment Indication
in Intermediate-Advanced HCC
B. Sangro
15:45 – 16.30
Case Studies: Management of Intermediate-Advanced HCC
(Including Stage Migration Concept)
J. Bruix, M. Reig, and A. Darnell
Tuesday 4 March 2014
C. Bru, Chair
09:00-09:30
Novel imaging techniques for HCC Management
J. Rimola
9:30 – 9:45
Questions & Answers
09:45-10:15
Current Perspectives on Ablation for the Treatment of HCC
L. Bianchi
10:15-10:45
Current Perspectives on TACE for the Treatment of HCC
M. Burrel
10:45-11:15
Radioembolization: Conventional Practice or Research?
S. Bhoori
11:15-11:30
Questions and Answers: Locoregional Approaches
11:30-12:00
Coffee Break
12:00-12:30
Resection and OLT: Restriction versus Expansion
P. Majno
12:30 – 12:45
Question and Answer
12:45 - 13:15
Tumor angiogenesis- translational aspects and clinical implications
of HCC management
D. Semela
13:15 – 13:30
Questions & answers
13:30 - 14:30
Lunch
14:30 - 15:15
Challenging the Dogma in HCC Management
J. Bruix
15:15 - 15:45
Intrahepatic cholangiocarcinoma: a review
J. Maurel
15:45 - 16:15
Viral Issues in Systemic Treatment and Liver Transplantation
X. Forns
16:15 – 16:30
16:30 - 17:00
Question and Answers
Prevention of Variceal Bleeding in HCC Patients
J. Bosch
17:00 – 17:15
Questions and Answers
17:15 – 17:45
Future Prospects in HCC Research
J. Bruix
17:45
Closing Remarks and Farewell
Visit to the research facilities (Dr. Boix) and Radiology Departments (Dr.
Liccioni and Dr. Vilana) at the close of today’s session
Download

kamp programı